China has granted Kenya and 52 other African nations duty-free access to its vast consumer market, a significant trade concession offering new growth avenues for Kenyan exporters.

• This policy allows 100% of tariff lines to enter China without import duties, effective May 1.
• Key Kenyan products like tea, coffee, avocados, and macadamia nuts are expected to benefit.
• Despite the opportunity, Kenyan exporters face challenges including production capacity, logistics, and quality standards, with competition from across Africa.

Kenya is considering a Sh27.8 billion biotechnology and pharmaceutical manufacturing park at Konza Technopolis to significantly reduce reliance on imported medicines and active pharmaceutical ingredients (APIs).

• The proposed project, submitted by APIFA Biotech, aims to establish a regional pharmaceutical manufacturing hub.
• A feasibility study is currently underway for the park, which will be developed on 2,000 acres under a Public-Private Partnership (PPP) arrangement.
• The initiative is inspired by India's bulk drug park model, featuring common user facilities to lower production costs for manufacturers and bolster Kenya's pharmaceutical independence, a vulnerability highlighted during the Covid-19 pandemic.

Kenya has formally entered the African Continental Free Trade Area (AfCFTA), aiming to boost its manufacturing exports, but faces significant non-tariff barriers hindering its success.

• Kenya shipped its first AfCFTA consignment in October 2022, a container of Exide batteries to Ghana.
• Despite strong policy support and identified priority sectors like pharmaceuticals and agro-processing, manufacturers report high transport costs, fragmented regulations, and inconsistent product standards as major obstacles.
• The Kenya Association of Manufacturers highlights that logistics inefficiencies and non-tariff barriers are now more significant impediments than tariffs for businesses trading across Africa.